1. Medtech Insight
  2. >>Policy & Regulation

Ostroff: Administration Coming Up To Speed On Planned FDA Guidances

There has been a dearth of guidances from US FDA since Donald Trump's inauguration, but the acting FDA commissioner says that simply reflects the new administration catching up on what's in the pipeline. In a speech at FDLI's annual meeting, Stephen Ostroff struck a positive tone.

FDA Acting Commissioner Stephen Ostroff speaking at the FDLI annual meeting.
FDA Acting Commissioner Stephen Ostroff speaking at the FDLI annual meeting May 4 in Washington, DC • Source: Ferdous Al-Faruque

US FDA Acting Commissioner Stephen Ostroff says the agency is waiting for the new administration to review its ongoing work before it releases new guidance documents.

Since the Trump administration came into power, there's been a noticeable dearth of guidances coming out of the agency. According to FDA's database, five draft and final guidance documents have...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation